Diabesity - novel molecular targets for obesity and type 2 diabetes
Next Member  
Previous Member  
Professor John-Olov Jansson Professor John-Olov Jansson
Institute of Neuroscience and  Physiology/Endocrine
Sahlgrenska Academy at Göteborg University
Box 434  Medicinarg. 11
SE-405 30
Professor John-Olov Jansson
DIABESITY IPR Officer and Workblock D leader


Our group has investigated the hormonal regulation of body fat mass.  Specifically, we have investigated the role of interleukin-6 (IL-6), and IL-1  in the regulation of body fat.  Circulating IL-6, in the absence of heavy exercise and inflammation, is to a large extent is produced by adipose tissue.  Using knockout mouse models, we have obtained evidence that both endogenous  IL-6 and IL-1 suppresses fat mass and prevents mature-onset obesity. There are  also data indicating that combined IL-6 and IL-1 deficiency causes early onset severe obesity. Both IL-6 and IL-1 exert their major anti-obesity effects at the level of the CNS, presumably the hypothalamus. Studies in humans indicated that polymorphisms of IL-6 and IL-1 system genes are associated with differences in body fat mass. For instance, the results of several studies show that the “weak” IL-6 -174C IL-6 gene promoter variant is associated with both decreased IL-6 production and obesity. Consequently, IL-6, IL-1 , and possibly also other parts of the immune system are important for regulation of fat mass in experimental animals and humans.



Diabesity: Novel molecular targets for obesity and type 2 diabetes
  home | research | publications | members | events | about diabesity | press | links | contact us